Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
524.00    4.00 (0.77%)
Bid:
524.00
Ask:
528.00
Spread: 4.00 (0.763%)
Market Cap: £867.04m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Dividend Declaration

14 Mar 2024 17:32

RNS Number : 9456G
Oakley Capital Investments Limited
14 March 2024

14 March 2024

Oakley Capital Investments Limited

Amendment to dividend timetable announced in the Annual Results

Oakley Capital Investments Limited1 ("OCI" or the "Company") notes the incorrect ex-dividend date announced in the Company's Annual Results today. The new timetable below shows the correct date. The record date and payment date remain as previously communicated.

Ex-Dividend date

(date from which shares are transferred without dividend)

21 March 2024

Record date

(last date for registering transfers to receive the dividend)

22 March 2024

Dividend payment date

26 April 2024

- ends -

For further information please contact:

Oakley Capital Limited

+44 20 7766 6900

Steven Tredget

Greenbrook Communications Limited

+44 20 7952 2000

Rob White / Michael Russell

Deutsche Numis (Financial Adviser & Broker)

+44 20 7260 1000

Nathan Brown / Matt Goss

Notes:

LEI Number: 213800KW6MZUK12CQ815

1 About Oakley Capital Investments Limited ("OCI")

OCI is a Specialist Fund Segment ("SFS") traded investment vehicle that aims to provide shareholders with consistent long-term capital growth in excess of the FTSE All-Share Index by providing liquid access to private equity returns through investment in the Oakley Funds.

A video introduction to OCI is available at https://oakleycapitalinvestments.com/videos/. The contents of the OCI website are not incorporated into, and do not form part of, this announcement.

Oakley Capital, the Investment Adviser

Founded in 2002, Oakley Capital Limited has demonstrated the repeated ability to source attractive growth assets at attractive prices. To do this it relies on its sector and regional expertise, its ability to tackle transaction complexity and its deal generating entrepreneur network.

The Oakley Funds

Oakley Capital Private Equity L.P. and its successor funds, Oakley Capital Private Equity II, Oakley Capital Private Equity III, Oakley Capital IV, Oakley Capital V, Oakley Capital Origin Fund and Oakley Capital Origin II, are unlisted lower-mid to mid-market private equity funds that aim to provide investors with significant long-term capital appreciation. The investment strategy of the Funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement. The Oakley family of funds also includes Oakley PROfounders Fund III and Oakley Touring Venture Fund, which are venture capital funds focused on investments in entrepreneur-led, disruptive, technology led companies.

For more information on the Oakley Fund strategies in which OCI invests, please click here.

Important information

Specialist Fund Segment securities are not admitted to the Official List of the Financial Conduct Authority. Therefore, the Company has not been required to satisfy the eligibility criteria for admission to listing on the Official List and is not required to comply with the Financial Conduct Authority's Listing Rules.

The Specialist Fund Segment is intended for institutional, professional, professionally advised and knowledgeable investors who understand, or who have been advised of, the potential risk from investing in companies admitted to the Specialist Fund Segment.

This announcement may include "forward-looking statements". These forward-looking statements are statements regarding the Company's objectives, intentions, beliefs or current expectations with respect to, amongst other things, the Company's financial position, business strategy, results of operations, liquidity, prospects and growth. Forward-looking statements are subject to risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Accordingly the Company's actual future financial results, operational performance and achievements may differ materially from those expressed in, or implied by, the statements. Given these uncertainties, prospective investors are cautioned not to place any undue reliance on such forward-looking statements, which speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect actual results or any change in the Company's expectations with regard to them or any change in events, conditions or circumstances on which any such statements are based unless required to do so by the Financial Services and Markets Act 2000, the Listing Rules or Prospectus Regulation Rules of the Financial Conduct Authority or other applicable laws, regulations or rules.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DIVEAXDLFANLEFA
Date   Source Headline
10th Nov 20224:15 pmRNSDirector/PDMR Shareholding
26th Oct 20227:00 amRNSTrading update for the 3 months ended 30 Sep 2022
13th Oct 20227:00 amRNSOakley Capital agrees partial exit from Wishcard
10th Oct 202211:55 amEQSHardman & Co Research : Q&A on Oakley Capital Investments (OCI) | 1H'22 results once again proving NAV is real and resilient
30th Sep 20223:00 pmRNSResult of AGM
20th Sep 20224:00 pmEQSHardman & Co Research on Oakley Capital Investments Ltd (OCI): 1H’22: results prove NAV real, resilient and growing
8th Sep 20227:00 amRNSInterim results for the 6 months ended 30 June 22
6th Sep 20227:00 amRNSOakley agrees follow-on investment in Facile.it
5th Sep 202212:26 pmRNSOakley Capital invests in vLex
5th Sep 20227:05 amRNSNotice of Annual General Meeting
30th Aug 202212:00 pmRNSOakley Capital invests in Phenna Group & CTS Group
26th Aug 20227:00 amRNSNotice of Results and Investor Presentation
25th Aug 20227:00 amRNSOakley Capital invests in Affinitas Education
8th Aug 20227:00 amRNSTransaction in Own Shares
27th Jul 202210:00 amRNSOakley Capital agrees partial exit from Seedtag
27th Jul 20227:00 amRNSTrading update for the 3 months ended 30 June 2022
26th Jul 20222:00 pmRNSOakley's Grupo Primavera to merge with Cegid
29th Jun 202212:50 pmRNSDirector Dealing
29th Jun 20227:00 amRNSTransaction in Own Shares
28th Jun 20227:00 amRNSTransaction in Own Shares
23rd Jun 20227:00 amRNSOakley Capital agrees sale of Facile.it
10th Jun 202211:05 amEQSHardman & Co Research: Q&A on Oakley Capital Investments: Impressive market and peer-beating 19% NAV CAGR growth 2017-21
8th Jun 20227:00 amRNSSale of Contabo and follow-on investment
16th May 20222:15 pmEQSHardman & Co Research: Oakley Capital Investments (OCI) - Capital Markets Day 2022 – let the sun shine
10th May 20227:00 amRNSDirector Dealing
9th May 20227:00 amRNSTransaction in Own Shares
6th May 20227:00 amRNSInvestment in Vice Golf
5th May 20227:00 amRNSTransaction in Own Shares
4th May 20227:00 amRNSTransaction in Own Shares
3rd May 20227:00 amRNSTransaction in Own Shares
27th Apr 20227:00 amRNSTrading update for the 3 months ended 31 March 22
19th Apr 20225:00 pmEQSHardman & Co: Q&A on Oakley Capital Investments Ltd: Proving the pudding: a sustainable growth model'
8th Apr 20221:38 pmRNSHolding(s) in Company
28th Mar 20227:00 amRNSTransaction in Own Shares
16th Mar 20222:45 pmEQSHardman & Co Research: Oakley Capital Investments Ltd (OCI) - Proving the pudding: a sustainable growth model
14th Mar 20223:04 pmRNSDirector Dealing
11th Mar 20226:17 pmRNSDirector Dealing
11th Mar 20229:08 amRNSResults analysis from Kepler Trust Intelligence
10th Mar 20227:04 amRNSShare Buy-Back Programme
10th Mar 20227:00 amRNSFinal Results for the year ended 31 December 2021
3rd Mar 20227:00 amRNSNotice of Results and Webcast Presentation
9th Feb 20228:30 amEQSHardman & Co Research: Oakley Capital Investments (OCI) Educating on education
31st Jan 202212:52 pmRNSDirector Dealing
31st Jan 202212:51 pmRNSDirector Dealing
28th Jan 20222:05 pmRNSDirector Dealing
27th Jan 20221:40 pmRNSFlash update from Kepler Trust Intelligence
26th Jan 20227:00 amRNSTrading Update for the Year Ended 31 December 2021
21st Dec 20217:00 amRNSNew Investment Advisory Agreement
17th Dec 20213:41 pmRNSHolding(s) in Company
16th Dec 20211:05 pmEQSHardman & Co Video : Hardman Talks | Everything you wanted to know about private equity but were afraid to ask!

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.